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Abstract 
As gastrointestinal motility disorders are frequently reported in patients with diabetes, we 
attempted to clarify the effects of cyclohexenonic long-chain fatty alcohol in type 2 
Goto-Kakizaki (GK) diabetic enteropathy. At 40 weeks of age male GK rats divided into three 
groups (treated with 0, 2 or 8 mg / kg of cyclohexenonic long-chain fatty alcohol; started at 
the age of 40 weeks).  Age-matched male Wistar rats were used in this study. At 70 week of 
age the ileal functions were estimated by organ bath studies using 100 mM KCl and carbachol. 
The expression levels of muscarinic M2 and M3 receptor mRNAs in the ileum were 
investigated by real-time polymerase chain reaction (PCR). Treatment with cyclohexenonic 
long-chain fatty alcohol did not alter the diabetic status of the GK rats, i.e., body weight, 
serum glucose, and serum insulin levels, but significantly ameliorated diabetes-induced 
hypercontractility of the rat ileum caused by carbachol in a dose-dependent manner.  
Although there were no significant differences in the expression levels of muscarinic M3 
receptor mRNAs in any of the groups, cyclohexenonic long-chain fatty alcohol reversed the 
diabetes-induced up-regulation of intestinal muscarinic M2 receptor mRNAs in treatment 
groups. These results indicate that cyclohexenonic long-chain fatty alcohol exerts its 
therapeutic effects on hypercontractility in the ileum of 70-week-old GK type 2 diabetic rats 
by ameliorating overexpression of muscarinic M2
 
 receptors. 
Index Words: type 2 diabetes, muscarinic receptor, cyclohexenonic long-chain fatty alcohol, 
ileum, Goto-Kakizaki (GK) rat 
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1. Introduction  
  Gastrointestinal dysfunctions such as delayed gastric emptying, diarrhea, constipation, and 
abdominal pain occurs in many diabetic patients. These dysfunctions are primarily cause by 
diabetes-induced neuropathy (Hosking et al., 1978; Thomas et al., 1987), which upsets the 
balance between the cholinergic and adrenergic systems within the enteric nervous system, 
thereby disrupting the gastrointestinal tone and causing reduced peristalsis and dysmotility. 
The streptozotocin-induced diabetic rat, which is the most commonly used and 
well-investigated experimental model for type 1 diabetes, exhibits typical alterations of 
gastrointestinal function (Shinbori et al., 2006; Narimatsu et al., 2007).  However, only 
limited information is available about enteropathy in rat models of type 2 diabetes.   
  The Goto-Kakizaki (GK) rat represents a spontaneous non-insulin-dependent diabetes 
model.  GK rats are produced from normal Wistar rats by repetition of selective breeding, 
and are a widely accepted genetically determined rodent model for human type 2 diabetes.  
This genetic rat model is particularly relevant to human type 2 diabetes because it exhibits 
defects in glucose-stimulated insulin secretion, peripheral insulin resistance, and 
hyperinsulinemia as early as four weeks after birth, with impairment of insulin secretion and 
resulting hypoinsulinemia occurring at later stages (Goto et al., 1976; Goto and Kakizaki, 
1981).   
  The tropical plant, Hygrophilia erecta Hochr., has been shown to contain some 
cyclohexenonic long-chain fatty alcohols that exert neurotrophic activities on cultured 
neurons from the cerebral cortex (Borg et al., 1987, 1990).  Cyclohexenonic long-chain fatty 
alcohol has been found to directly increase the neurite extension as well as the biochemical 
differentiation of these neurons.  In addition, we have reported that cyclohexenonic 
long-chain fatty alcohol prevented the progression of diabetes-induced alterations of the 
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trachea, aorta, and bladder (Satoh et al., 2005; Shinbori et al., 2007; Saito et al., 2007).  In 
other previous reports, we demonstrated that cyclohexenonic long-chain fatty alcohol 
ameliorated the progression of diabetes-induced dysfunction of the ileum in 
streptozotocin-induced diabetic rats (Shinbori et al., 2006; Narimatsu et al., 2007).  In the 
previous reports, although cyclohexenonic long-chain fatty alcohol did not improve the 
general features or serum glucose and insulin levels of the streptozotocin-induced diabetic rats, 
it significantly improved the thickness of the ileal wall and hypercontractility of the rat ileum 
in response to carbachol in a dose-dependent manner, and the improvement of 
hypercontractility was accomplished without qualitative alteration of the muscarinic receptor 
system (Shinbori et al., 2006; Narimatsu et al., 2007).  From these reports, we propose that 
cyclohexenonic long-chain fatty alcohol may prevent not only type 1 diabetic peripheral 
neuropathy in the ileum, but also type 2 diabetes; furthermore, these effects appear to take 
place independently of increases of insulin and serum glucose.   
  Therefore, the aims of this study were to investigate type 2 diabets-induced changes in the 
muscarinic receptor system in the rat ileum, and to clarify the effects of cyclohexenonic 
long-chain fatty alcohol on possible alterations of the muscarinic receptor system in the type 2 
rat diabetic ileum.
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2. Materials and Methods 
2.1. Animal models 
All animal experiments were performed in accordance with the guidelines established by the 
Tottori University Committee for Animal Experimentation.  Six-week-old male GK and 
Wistar rats were purchased from SLC (Shizuoka, Japan).  All rats were kept under identical 
conditions, and had access to food and drinking water ad libitum.  At the age of 12 weeks, 
seven Wistar and seven GK rats were used for preliminary functional studies.  Then, the 
remaining rats were divided randomly into four groups (n = 6-8 each): a group of 
age-matched Wistar rats treated with vehicle (A), a group of diabetic GK rats treated with 
vehicle (B), a group of diabetic GK rats treated with cyclohexenonic long-chain fatty alcohol, 
2,4,4-trimethyl-3-(15-hydroxypentadecyl)-2-cyclohexen-1-one, at a daily dose of 2 mg/kg 
intramuscularly (C), and a group of diabetic GK rats treated with cyclohexenonic long-chain 
fatty alcohol at a daily dose of 8 mg/kg intramuscularly (D).  Figure 1 shows the chemical 
structure of this compound (Shinbori et al., 2007; 2008). A mixture of ethanol:saline:Tween 
80 in the ratio 5:92.15:2.85 (the total volume was 1 ml/kg body weight) was used as a vehicle 
throughout this study (Saito et al., 2006: 2007, Shinbori et al., 2007; 2008). The drug or 
vehicle administrations were started at the age of 40 weeks in each animal.  Upon reaching 
70 weeks of the age, the rats were sacrificed with an overdose of pentobarbital (60 mg i.p.).  
Blood samples were collected from the vena cava, and the ileum was removed from each 
animal and placed in Krebs–Henseleit solution.  These blood samples were frozen at –80℃ 
until used.  The rat ileum was immediately used for functional studies, and the rest of the 
tissue was frozen at –80℃ for measurement of muscarinic M2 and M3
 
 receptor mRNAs. 
2.2. Serum glucose and insulin measurement 
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Serum glucose concentrations were measured by the hexokinase method using a Glucose CⅡ
kit (Wako Pure Chemicals, Osaka, Japan) according to the manufacturer's instructions in all 
groups.  The insulin concentrations were also measured by a Rat Insulin ELISA kit 
(Mercodia AB, Uppsala, Sweden) according to the manufacturer's instructions. 
 
2.3. Measurement of contractile force in the isolated ileum 
The functional studies were performed according to our previous reports (Shinbori et al., 
2006; Narimatsu et al., 2007).  The ileum was rinsed with Krebs-Henseleit solution, the most 
distal 10 cm discarded, and the remaining ileum cut into approximately 1 cm segments.  The 
ileal segments were mounted longitudinally between a hook in the bottom of the muscle 
chamber and a force displacement transducer in an organ bath (25 ml) containing 
Krebs-Henseleit solution, and bubbled with 5% CO2 and 95% O2 (37℃).  One hook was 
suspended from a transducer (type 45196A; San-ei Instruments, Tokyo, Japan), and the lower 
hook was fixed to a plastic support leg to a micrometer (Mitutoyo, Tokyo, Japan).  The ileum 
preparations were equilibrated unstretched for 30 min.  A load of 1.0 g was applied to each 
strip by micrometer adjustment, and the load was readjusted to this level 30 min later.  
Changes in the tone of the strips were induced by means of a force transducer, and recorded 
on a personal computer (Macintosh G3; Apple Computer, Cupertino, CA) by use of Chart v 
3.6.9 software and a PowerLab/16sp data acquisition system (AD Instruments, Castle Hill, 
Australia).  Cumulative concentration-response curves to carbachol (10-8 – 3×10-5
 
 M) and 
KCl (100 mM) were recorded.  
2.4. Real-time polymerase chain reaction (PCR) of muscarinic M2 and M3 receptor 
mRNAs 
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Measurement of muscarinic receptor mRNAs was performed according to a method outlined 
in our previous reports (Shinbori et al., 2006; Narimatsu et al., 2007; Saito et al., 2007).  
Muscarinic M2 and M3 receptor mRNAs in the experimental ileum were measured by 
real-time PCR.  The mRNAs were purified using an RNeasy Mini Kit (Qiagen, Valencia, 
CA) according to the manufacturer's instructions. The reverse transcriptase (RT) mixture (20 
ml) containing 2 mg of total RNA was prepared and incubated at 37°C for 60 min according 
to a previously reported method (Shinbori et al., 2006; Narimatsu et al., 2007; Saito et al., 
2007).  Fifteen microliters of the mixture were used for real-time PCR, which was carried 
out using a Light Cycler thermal cycler system with a LightCycler-FastStart Hybridization 
Probe kit according to the manufacturer's instructions (Roche Diagnostics, Tokyo, Japan).  
The primers and probes were synthesized commercially by Nihon Gene Research 
Laboratories, Inc. (Sendai, Japan), and these sequences are shown in Table 1.  The predicted 
product sizes of muscarinic M2 and M3
 
 receptors were 148 bp and 149 bp, respectively.  The 
primer and probe of the β-actin used were from the LightCycler-Primer/Probe Set (rat). 
β-actin was used as the internal standard.  A total of 5 ml of solution was used for the 
sample.  
2.5. Data analysis 
The data for contractions induced by carbachol were normalized by those of 100 mM KCl.  
The EC50 and Emax values were obtained by using a Macintosh computer (G3) loaded with 
Chart v3.6.9 software and a PowerLab/16sp data acquisition system.  The expression of 
muscarinic M2 and M3 receptor mRNAs was quantified according to the expression of β-actin 
mRNAs in the experimental rat ileum.  A statistical comparison of differences between 
groups was performed using analysis of variance and Fisher’s multiple comparison tests.  
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Values of P<0.05 were considered to indicate statistical significance. 
 
2.6. Drugs and chemicals 
Cyclohexenonic long-chain fatty alcohol, 
2,4,4-trimethyl-3-(15-hydroxypentadecyl)-2-cyclohexen-1-one, was obtained from Meiji Milk 
Products Co., Ltd. (Tokyo, Japan).  All other chemicals used were of reagent grade.  
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3. Results 
3.1. General features of the experimental rats 
The general features of the experimental rats are shown in Figure 2 and Table 2.  The GK 
diabetic rats showed significantly lower weight gain by the age of 10 weeks, as well as 
significantly lower weight gain during the experimental period compared with the controls 
(p<0.05) (Figure 2).  Significantly higher serum glucose levels were confirmed at the age of 
12 weeks in the GK diabetic rats compared with the controls (153.4 ± 7.9 and 233.1 ± 12.3 
mg/dl for the Wistar and GK rats, respectively; p<0.05).  The 70-week-old GK diabetic rats 
also showed significantly higher serum glucose and lower serum insulin levels than those of 
the control rats.  Treatment with cyclohexenonic long-chain fatty alcohol did not improve 
the body weight gains during the observation periods, and had no effect on serum glucose or 
insulin levels.  
 
3.2. Measurement of contractile force in the isolated ileum 
The Emax and EC50 values for the contractile responses of the ileal smooth muscles to 
carbachol (10-8 – 3×10-5 M) and KCl (100 mM) were determined (Table 3).  At the age of 
12 weeks, there was no significant difference in Emax values between Wistar and GK rats. 
However, significant hypercontractility to carbachol was observed in the ileum of 
70-week-old GK rats.  Diabetes-induced ileal hypercontractility to carbachol was 
significantly ameliorated by the high-dose (8 mg/kg) treatment with cyclohexenonic 
long-chain fatty alcohol.  The EC50
 
 values obtained in response to carbachol indicated were 
not significantly difference among the four groups.  
3.3. Real-time PCR analysis of muscarinic M2 and M3 receptor mRNAs 
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Figure 3 shows the expressions of muscarinic M2 and M3 receptor mRNAs in the ileum as 
assessed by real-time PCR.  In the untreated diabetes group (group B), the expressions of 
muscarinic M2 receptor mRNAs were significantly higher than those in the controls (group 
A).  Treatment with both doses of cyclohexenonic long-chain fatty alcohol significantly 
improved the up-regulation of muscarinic M2 receptor mRNAs.  The expressions of 
muscarinic M3 receptor mRNAs in the untreated diabetes group, tended to be higher than 
those in age-matched Wistar rats.  However, because of the large variations in each group, 
these differences were not significantly different.  Treatment with cyclohexenonic long-chain 
fatty alcohol tended to ameliorate diabetes-induced overexpression of muscarinic M3 receptor 
mRNAs; the expression levels of muscarinic M3 receptor mRNAs in GK rats treated with 
both doses were close to that of control Wistar rats.  However, no significant differences in 
the expressions of muscarinic M3 receptor mRNAs were found among the four groups. 
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4. Discussion 
  Several studies have examined contractile responses of ileal smooth muscle to 
acetylcholine or cholinergic agonists in streptozotocin-induced diabetes, and have 
alternatively reported that the responses are elevated (Shinbori et al., 2006; Narimatsu et al., 
2007; Carrier and Aronstam, 1990; Anjaneyulu and Ramarao, 2002; Talubmook et al., 2003) 
or decreased (Lucas and Sardar, 1991; Coulson et al., 2002). Interestingly, Daneshgari and 
associates reported that diabetic bladders may undergo a transition from a compensated to a 
decompensated state and that this transition in the streptozotocin rat model may begin at 9 to 
12 weeks after the induction of diabetes (Daneshgari et al., 2006).  It may be that the same 
phenomenon occurs in the streptozotocin-induced diabetic rat ileum, and thus the conflicting 
results described above may have been due to the durations of the diabetic periods.   
  However, the majority of human diabetes is type 2.  There are some reports indicating that 
neuropathy in type 1 diabetes is different from that in type 2 diabetes (Schmidt et al., 2003, 
2004; Kamiya et al., 2005), and only limited information is available in regard to ileal 
dysfunction in type 2 diabetic models. In the present study, although there was no significant 
difference of Emax values for carbachol between Wistar and GK rats at the age of 12 weeks, 
we clearly demonstrated the hypercontractility of detrusor smooth muscle in response to 
carbachol in GK rats at the age of 70 weeks compared to age-matched Wistar rats.  These 
data were similar to those for streptozotocin-induced diabetic rats previously reported 
(Shinbori et al., 2006; Narimatsu et al., 2007). These data are particularly interesting because 
early-stage streptozotocin-induced diabetic rats and late-stage GK rats show similar patterns 
of ileal dysfunction.  In previous studies, we showed that significant alterations of the ileal 
muscarinic receptor system occurred over the eight-week period of streptozotocin-induced 
diabetes (Shinbori et al., 2006; Narimatsu et al., 2007). Thickening the ileal wall, 
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hypercontractility in response to carbachol, and up-regulations of the expressions of 
muscarinic M2 and M3
  As regards the role of muscarinic receptors, we have suggested that the rat ileum undergoes 
contractions mainly via the muscarinic M
 receptor mRNAs were observed in the streptozotocin-induced diabetic 
rat ileum.  These alterations of the muscarinic receptor system in the rat ileum were 
quantitative rather than qualitative pharmacologically and biologically (Shinbori et al., 2006; 
Narimatsu et al., 2007). 
3 receptor subtype using pharmacological methods 
(Narimatsu et al., 2007).  However, based on the results of previous studies, we can not rule 
out the possibility that the muscarinic M2 receptor subtype does not directly contribute to 
cholinergic contractions.  In addition, Unno et al. reported results for muscarinic 
M2-knockout, muscarinic M3-knockout, muscarinic M2/M3-double knockout, and wild-type 
mice, demonstrating that muscarinic M2 and M3 receptors participate in mediating cholinergic 
contractions in the mouse ileum, with the latter subtype of receptors assuming a substantial 
role in this process (Unno et al., 2006).  In order to clarify the mechanisms underlying type 2 
diabetic enteropathy, we undertook to measure the expression levels of muscarinic M2 and 
M3 receptor mRNAs utilizing real-time PCR methods.  In this study, we found that 
muscarinic M2 receptor mRNAs were significantly up-regulated, and muscarinic M3 receptor 
mRNAs were slightly up-regulated in the ileum of 70-week-old GK type 2 diabetic rats. The 
lack of statistical significance in the latter result may have been due to the small size of the 
groups we studied. The possible mechanisms of this up-regulation of muscarinic receptors are 
thought to include a decrease in cholinergic nerve density, or a defect in the neurotransmitter 
release mechanism (Miyamae et al., 2004; Tong et al., 1996).  The diabetes-associated 
neuropathy may inhibit the release of acetylcholine from cholinergic nerves, in turn inducing 
the overexpression of muscarinic receptors in the diabetic ileal smooth muscle.  Such 
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overexpression may enhance signaling downstream of these receptors and may increase 
smooth muscle contraction, according to the results of the present organ bath study.  
  Cyclohexenonic long-chain fatty alcohol was first reported to have neurotrophic activities 
on cultured neurons from the cerebral cortex (Borg et al., 1987, 1990).  The C26-alcohol, 
N-hexacosanol, has been found to directly increase neurite extension as well as biochemical 
differentiation of these neurons.  Watanabe and Miyagawa reported that cyclohexenonic 
long-chain fatty alcohol has beneficial effects on peripheral neuropathy and cystopathy in 
streptozotocin-induced diabetic rats (Watanabe and Miyagawa, 2002).  They also 
demonstrated that diabetes-induced alteration of motor sciatic nerve conduction is normalized 
by treatment with cyclohexenonic long-chain fatty alcohol (Watanabe and Miyagawa, 2002).  
In more recent studies, our group has investigated mainly therapeutic and/or preventive 
effects on streptozotocin-induced cystopathy, enteropathy, angiopathy, nephropathy, and 
tracheal dysfunction (Narimatsu et al., 2007; Okada et al., 2008; Saito et al., 2006, 2007; 
Shinbori et al., 2006, 2007; Suzuki et al., 2006). We found that cyclohexenonic long-chain 
fatty alcohol has no effect on serum insulin or glucose levels in streptozotocin-induced 
diabetic animals, but that it has therapeutic and/or preventive effects on 
streptozotocin-induced cystopathy, enteropathy, angiopathy, nephropathy, and tracheal 
dysfunction.  Recently, we have also reported that streptozotocin-induced diabetes caused 
alterations of amino acid components in the central nervous system of rats, and that treatment 
with cyclohexenonic long-chain fatty alcohol significantly ameliorated these alterations 
(Shinbori et al., 2008).  These reports strongly suggest that cyclohexenonic long-chain fatty 
alcohol has therapeutic and/or preventive effects on not only peripheral neuropathy but also 
central neuropathy induced by streptozotocin.  In this study, we also investigated the 
therapeutic effects of cyclohexenonic long-chain fatty alcohol on type 2 diabetes-induced ileal 
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alterations.  We clearly demonstrated that cyclohexenonic long-chain fatty alcohol 
significantly ameliorated diabetes-induced hypercontractility of the rat ileum in response to 
carbachol, and that cyclohexenonic long-chain fatty alcohol reversed the diabetes-induced 
up-regulation of intestinal muscarinic M2 receptor mRNAs in the rats.  From this study, 
although the precise mechanisms are unclear, it is clear that cyclohexenonic long-chain fatty 
alcohol reduces hypercontractility of the ileum of 70-week-old GK type 2 diabetic rats by 
ameliorating overexpression of muscarinic M2
  In conclusion, our data indicate that cyclohexenonic long-chain fatty alcohol ameliorates  
hypercontractility in the ileum of 70-week-old GK type 2 diabetic rats by ameliorating 
overexpression of muscarinic M
 receptor proteins and mRNAs.  The 
physiological and pharmacological role of cyclohexenonic long-chain fatty alcohol in type 2 
diabetes mellitus, however, remains unclear and warrants further study. 
2 receptor and possibly M3 receprot subtypes. 
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Figure legends 
Figure 1.  The chemical structure of cyclohexenonic long-chain fatty alcohol, 
2,4,4-trimethyl-3-(15-hydroxypentadecyl)-2-cyclohexen-1-one. 
 
Figure 2.  Body weight in GK and Wistar rats.  
A: Wistar rats; B: GK rats treated with vehicle; C: GK rats treated with 2 mg/kg of 
cyclohexenonic long-chain fatty alcohol; D: GK rats treated with 8 mg/kg of cyclohexenonic 
long-chain fatty alcohol.  Data are shown as the means ± SEM of six to eight separate 
determinations in each group. *Significantly different from the other groups of age-matched 
rats.  
 
Figure 3A and 3B.   Expressions of muscarinic M2 and M3
A: Wistar rats; B: GK rats treated with vehicle; C: GK rats treated with 2 mg/kg of 
cyclohexenonic long-chain fatty alcohol; D: GK rats treated with 8 mg/kg of cyclohexenonic 
long-chain fatty alcohol.  All data were normalized by b-actin.  Data are shown as the 
means ± SEM of six to eight separate determinations in each group. *Significantly different 
from the other groups of age-matched rats. 
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